View in EDS

Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong.

Saved in:
Bibliographic Details
Title: Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong.
Authors: Blais JE; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China., Yan VK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China., Zhao J; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Digital and Data Innovation, AstraZeneca Global R&D (China) Co, Ltd, 200000 Shanghai, China., Chui CS; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; School of Nursing, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China., Wong IC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.; Aston Pharmacy School, Aston University, B4 7ET Birmingham, UK., Siu CW; Division of Cardiology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China., Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.; Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, 518000 Shenzhen, GuangDong, China.; The University of Hong Kong Shenzhen Institute of Research and Innovation, 518000 Shenzhen, GuangDong, China.
Source: Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2022 Sep 26; Vol. 23 (10), pp. 327. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: IMR Press Country of Publication: Singapore NLM ID: 100960007 Publication Model: eCollection Cited Medium: Internet ISSN: 2153-8174 (Electronic) Linking ISSN: 15306550 NLM ISO Abbreviation: Rev Cardiovasc Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39077145
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Blais+JE%22">Blais JE</searchLink>; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Yan+VK%22">Yan VK</searchLink>; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Digital and Data Innovation, AstraZeneca Global R&D (China) Co, Ltd, 200000 Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chui+CS%22">Chui CS</searchLink>; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; School of Nursing, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Wong+IC%22">Wong IC</searchLink>; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.; Aston Pharmacy School, Aston University, B4 7ET Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Siu+CW%22">Siu CW</searchLink>; Division of Cardiology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Chan+EW%22">Chan EW</searchLink>; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.; Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, 518000 Shenzhen, GuangDong, China.; The University of Hong Kong Shenzhen Institute of Research and Innovation, 518000 Shenzhen, GuangDong, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100960007%22">Reviews in cardiovascular medicine</searchLink> [Rev Cardiovasc Med] 2022 Sep 26; Vol. 23 (10), pp. 327. <i>Date of Electronic Publication: </i>2022 Sep 26 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22IMR+Press%22">IMR Press </searchLink><i>Country of Publication: </i>Singapore <i>NLM ID: </i>100960007 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2153-8174 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215306550%22">15306550 </searchLink><i>NLM ISO Abbreviation: </i>Rev Cardiovasc Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39077145
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.31083/j.rcm2310327
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 327
    Titles:
      – TitleFull: Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Blais JE
      – PersonEntity:
          Name:
            NameFull: Yan VK
      – PersonEntity:
          Name:
            NameFull: Zhao J
      – PersonEntity:
          Name:
            NameFull: Chui CS
      – PersonEntity:
          Name:
            NameFull: Wong IC
      – PersonEntity:
          Name:
            NameFull: Siu CW
      – PersonEntity:
          Name:
            NameFull: Chan EW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 09
              Text: 2022 Sep 26
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2153-8174
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Reviews in cardiovascular medicine
              Type: main
ResultId 1